Security key
45258H106
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 27,077,219
- Total 13F value
- $246,615,159
- Share change
- +1,770,592
- Put/Call ratio
- 352%
- SEC-reported price per share
- $9.11
- Number of holders
- 76
- Value change
- +$26,862,251
- Number of buys
- 48
- Number of sells
- 24
- Shares outstanding
- 69,928,708
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
76
Top holders
10
IMMX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q3 2025
Immix Biopharma, Inc. SEC filings
Immix Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45258H106
Recent filing periods:
Ownership snapshot
Top reported holders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Saturn V Capital Manageme...
Disclosed value leader
Janus Henderson Group Ltd.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 7%
13D/G row: Saturn V Capital Management LP
Showing 1-6 of 15 holder rows.
Quick read
Saturn V Capital Management LP leads the comparable SEC ownership view at 7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Saturn V Capital Management LP's linked filing trail.
Comparable ownership
Top 5
Saturn V Capital Management LP
7%
MILLENNIUM MANAGEMENT LLC
3.3%
Janus Henderson Group Ltd.
5.6%
EVENTIDE ASSET MANAGEMENT, LLC
3.6%
MARSHALL WACE, LLP
2.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Saturn V Capital Management LP |
13D/G
13F
Company
|
7%
|
$17,987,759
3,693,585 shares
|
$0 | 26 Dec 2025 |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
Company
|
3.3%
|
$16,959,438
1,750,200 shares
|
-$10,291,071 | 31 Mar 2026 |
| Janus Henderson Group Ltd. |
13F
Company
|
5.6%
|
$20,470,585
3,921,568 shares
|
— | 31 Dec 2025 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
3.6%
|
$13,331,369
2,549,019 shares
|
— | 31 Dec 2025 |
| MARSHALL WACE, LLP |
13F
Company
|
2.8%
|
$10,348,824
1,978,743 shares
|
— | 31 Dec 2025 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
2.1%
|
$7,845,000
1,500,000 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
76
Shares
27,077,219
Rows available
76
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q3 2025 Across Filers
Q3 2025 holders
31
Q1 2026 holders
76
Holder diff
45
| Investor | Q3 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend